In a study of 78 adults with CKD stages 3 to 4, lower hepcidin levels were predictive of erythropoietic response to intravenous iron supplementation, albeit with sensitivity 84% and specificity of only 48% [57]. Here, HAMP is linked to chronic kidney disease.